-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Initiates Coverage On Mira Pharmaceuticals with Buy Rating, Announces Price Target of $3.5

Benzinga·09/17/2026 15:10:06
语音播报
Maxim Group analyst Jason McCarthy initiates coverage on Mira Pharmaceuticals (NASDAQ:MIRA) with a Buy rating and announces Price Target of $3.5.